Video
Author(s):
In early testing the bionic pancreas has shown strong results for treating patients with type 1 diabetes. Over the next two years more work will go into streamlining the device and further testing in hopes of receiving FDA approval.
In early testing the bionic pancreas has shown strong results for treating patients with type 1 diabetes. Over the next two years more work will go into streamlining the device and further testing in hopes of receiving FDA approval.
Edward Damiano, PhD, from Boston University discussed the next steps taken by the team as they work to bring the device to the market during the American Association of Clinical Endocrinologists 24th Annual Scientific and Clinical Congress in Nashville.